Abstract:BackgroundThe production of therapeutically active single chain variable fragment (scFv) antibody is still challenging in E. coli due to the aggregation propensity of recombinant protein into inclusion bodies (IBs). However, recent advancement of biotechnology has shown substantial recovery of bioactive protein from such insoluble IBs by solubilization and refolding processes. In addition, gene fusion technology has also widely been used to improve the soluble protein production using E. coli. This study demonstrates that mild-solubilization and in vitro refolding strategies, both are capable to recover soluble scFv protein from bacterial IBs, although the degree of success is greatly influenced by different fusion tags with the target protein.ResultsIt was observed that the most commonly used fusion tag, i.e., maltose binding protein (MBP) was not only influenced the cytoplasmic expression in E. coli but also greatly improved the in vitro refolding yield of scFv protein. On the other hand, mild solubilization process potentially could recover soluble and functional scFv protein from non-classical IBs without assistance of any fusion tag and in vitro refolding step. The recovery yield achieved by mild solubilization process was also found higher than denaturation–refolding method except while scFv was refolded in fusion with MBP tag. Concomitantly, it was also observed that the soluble protein achieved by mild solubilizationprocess was better structured and functionally more active than the one achieved by in vitro refolding method in the absence of MBP tag or refolding enhancer.ConclusionsMaltose binding protein tagged scFv has shown better refolding and solubility yields as compare to mild solubilization process. However, in terms of cost, time and tag free nature, mild solubilization method for scFv recovery from bacterial IBs is considerable for therapeutic application and further structural studies.

A rapid method for solubilization of chimeric human interferon regulatory factor-1 (IRF-1) protein in Escherichia coli

Optimization of soluble human interferon-γ production in Escherichia coli using SUMO fusion partner

Evaluating the ability of different chaperones in improving soluble expression of a triple-mutated human interferon gamma in Escherichia coli

Optimization of conditions for high-level expression and purification of human recombinant consensus interferon (rh-cIFN) and its characterization

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners.

A Simplified Process for Purification and Refolding of Recombinant Human Interferon-α2b

Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process

Soluble expression of human insulin-like growth factor-1 with the assistance of SUMO fusion partner

Soluble Expression of Human Leukemia Inhibitory Factor with Protein Disulfide Isomerase in Escherichia coli and Its Simple Purification

Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-denaturing and Refolding Method.

[Fusion Expression, Purification and Bioassay of IFN-gamma Inducible Protein-10 and Thioredoxin Gene in E. Coli].

Prokaryotic expression of soluble IFN-λ1 recombinant protein with cold-shock system

Refolding of Recombinant Human Interferon Gamma Inclusion Bodies in Vitro Assisted by Colloidal Thermo-Sensitive Poly(n-Isopropylacrylamide) Brushes Grafted Onto the Surface of Uniform Polystyrene Cores

Study on the Purification Technology of Recombinant Human Interferon-γ

Identification of Optimal Expression Parameters and Purification of a Codon-Optimized Human GLIS1 Transcription Factor from Escherichia coli

Solvent extraction of recombinant interferon alpha-2b from inclusion bodies and efficient refolding at high protein concentrations

Soluble expression of recombinant human interleukin-2 in Escherichia coli and its facile production

Refolding and Purification of Interferon-Gamma in Industry by Hydrophobic Interaction Chromatography

[Preparation and Identification of Recombinant Human Interferon-Gamma].

Efficient Recovery of the Functional IP10-scFv Fusion Protein from Inclusion Bodies with an On-Column Refolding System.